Delivery Order SPE2DB24D2205-SPE2DB25FEGFF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,702.70 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,762.92 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a injectable medication used in diabetes management, reflecting the pharmaceutical distributor's core role in...
- The Defense Logistics Agency awarded a delivery order valued at $7,961.64 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be performed at the contractor's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.09 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 21, 2025, with completion expected by August 22, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,291.68 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 25, 2025, with completion anticipated by August 26, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication commonly used in military...
- The Defense Logistics Agency awarded a $5,377.02 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml dose). This firm fixed price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $34,772.86 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion date of September 11, 2025. This firm fixed price contract, which is not set-aside and was competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,844.77 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGFFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,167.48 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 13, 2025. This competitively awarded, firm fixed-price contract represents a single delivery transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. Trulicity is a diabetes medication commonly used within military and federal healthcare systems to support patient treatment across the Department of Defense medical supply chain. This delivery order is a child contract under AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical, designated SPE2DX and running through December 2026. The parent contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor for Defense Health Agency and other government healthcare systems, with the company selected through open competition to fulfill ongoing federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/13/25 |